DDMAC

AcronymDefinition
DDMACDivision of Drug Marketing, Advertising and Communications
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Judges coded an FDA letter either as a "Warning Letter" that prompted compliance with the FDA guidelines (such letter is titled "Warning Letter" by DDMAC) or as an "Untitled Letter" that did not include a title and a warning statement.
In the first step, 25.0 mL [Pb.sup.2+] solution or water samples, 2mL of [Na.sub.2]HP[O.sub.4]/NaOH buffer solution, 1 mL of 0.5% (w/v) CR solution, 100 [micro]L 8% (v/v) DDMAC, and 0.1 g NaCl were mixed.
The work of DDMAC also includes monitoring and surveillance, attending medical conferences, and reviewing websites and complaints.
Although DDMAC's enforcement activities appear to have waned in 2011, other enforcement activities based on prescription drug marketing are growing at a rapid rate.
The DDMAC (65) will conduct a promotional review of the proposed proprietary drug name.
"The Bad Ad program will help health care providers recognize misleading prescription drug promotion and provide them with an easy way to report this activity to the agency," explains Thomas Abrams, director of the DDMAC.
It is not a controlled substance, as are competitors in the sedative-hypnotics class, but that difference alone does not "confer added safety," the DDMAC said.
Specifically, the DDMAC says a sell sheet focused on substance abuse patients is false or misleading because it makes unsubstantiated superiority presentations and omits and minimizes risks.
(136) The DDMAC informed the GAO that they received more materials than the agency could review.
To ensure that drug manufacturers comply with DTC advertising requirements, the FDA established the Division of Drug Marketing, Advertising, and Communications ("DDMAC").
Project management is particularly helpful for providing structure and focus through the tumultuous ride from phase III clinical trials, filing a new drug application, arm-wrestling with and obtaining FDA approval, working with the Division of Drug Marketing, Advertising, and Communications (DDMAC), and navigating the many options and choices through the early years of a product's launch and commercialization.